Posted on

U.S. states face steep decline in J&J Covid vaccine amid production problems at Baltimore plant



Share

Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021.Dado Ruvic | ReutersJohnson & Johnson is scaling back shipments of its single-dose Covid-19 vaccine by 86% next week as it grapples with manufacturing issues at a major plant in Baltimore.The government has allocated only 700,000 J&J shots to states next week, down from 4.9 million the week prior, according to data from the Centers for Disease Control and Prevention.J&J is awaiting regulatory clearance for a Baltimore facility, which is run by Emergent BioSolutions Inc, and is working with the …

Read More